Health Condition 1: J069- Acute upper respiratory infection,unspecified
Conditions
Interventions
Intervention1: URAI MATHIRAI: 50 MG DAILY UPTO SIX MONTHS
Control Intervention1: THALEESATHI CHOORANAM: 1 GRAM TWICE DAILY FOR SIX MONTHS
Sponsors
CENTRAL COUNCIL FOR RESEARCH IN SIDDHA
Eligibility
Inclusion criteria
Inclusion criteria: Children of either gender aged 6 MONTHS to 6 Years with a history of recurrent URTIs and presenting with URTI at hospital treatment. � The definition used for recurrent URTIs was three or more such episodes during the last 12 months. � The current episode required for study eligibility was Defined by the presence of at least two of the following Rhinitis Pharyngitis cough hoarseness, Temperature More than 38.5�°C, Prescription of an antibiotic for a URTI, occurring after an asymptomatic Period of at least 1 week without antibiotics
Exclusion criteria
Exclusion criteria: occurrence of otitis media and/or sinusitis and/or infection of the lower respiratory tract (ie, bronchitis, pneumonia)and/or proven group A streptococcal angina at the enrollment Further main exclusion criteria were allergic asthma, significant systemic disease (eg, hepatic and/or renal disease, malignancy), immune system disorders, suspected Malabsorption, major surgical procedure within 3 months of commencement of the study recent immunosuppressive or immunostimulant therapy, or corticosteroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in Recurrence of Resp Infections Clinical Improvement No Antibiotic treatment Increase in Anti bodies IgA/IgG Decrease in Phagocytosis Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of trial drugTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactDRPSATHIYARAJESWARAN
SIDDHA CENTRAL RESEARCH INSTITUTE
Outcome results
None listed